Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10060733HBVENSG00000118271.12protein_codingTTRNoNo7276P02766
TVIS10060734HBVENSG00000118271.12protein_codingTTRNoNo7276P02766
TVIS30079529HIVENSG00000118271.12protein_codingTTRNoNo7276P02766
TVIS20053630HPVENSG00000118271.12protein_codingTTRNoNo7276P02766
TVIS20045816HPVENSG00000118271.12protein_codingTTRNoNo7276P02766
TVIS44021205HTLV-1ENSG00000118271.12protein_codingTTRNoNo7276P02766
TVIS44034752HTLV-1ENSG00000118271.12protein_codingTTRNoNo7276P02766
TCGA Plot Options
Drug Information
GeneTTR
DrugBank IDDB11644
Drug NameTafamidis
Target IDBE0000337
UniProt IDP02766
Regulation Typechaperone
PubMed IDs31735731
CitationsEndo J, Sano M, Izumiya Y, Tsujita K, Nakamura K, Tahara N, Kuwahara K, Inomata T, Ueda M, Sekijima Y, Ando Y, Tsutsui H, Isobe M, Fukuda K: A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis. Circ J. 2019 Dec 25;84(1):15-17. doi: 10.1253/circj.CJ-19-0811. Epub 2019 Nov 16.
GroupsApproved; Investigational
Direct ClassificationPhenyl-1,3-oxazoles
SMILESOC(=O)C1=CC=C2N=C(OC2=C1)C1=CC(Cl)=CC(Cl)=C1
Pathways
PharmGKB
ChEMBLCHEMBL2103837